Related Experiment Video

Updated: Apr 1, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

Splicing and Dicing MYC-Mediated Synthetic Lethality

Zachary E Stine1, Chi V Dang1

  • 1Abramson Family Cancer Research Institute, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cancer Cell
|October 14, 2015
PubMed

Insights

Oncogenic MYC activation creates a vulnerability in cancer cells, making them dependent on the spliceosome for survival. Inhibiting the spliceosome offers a promising synthetic lethal strategy for targeting MYC-driven tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The MYC oncogene plays a critical role in cell proliferation and is frequently dysregulated in various cancers.
  • Directly targeting MYC has proven challenging due to its function as a transcription factor.
  • Synthetic lethality, where the combination of two genetic defects is lethal but individual defects are not, offers an alternative therapeutic strategy.

Purpose of the Study:

  • To investigate the synthetic lethal interactions associated with oncogenic MYC activation.
  • To explore the potential of targeting the spliceosome as a therapeutic strategy for MYC-driven cancers.

Main Methods:

  • The study by Hsu and colleagues likely involved genetic screens or drug-based assays to identify vulnerabilities in cells with activated MYC.
  • Analysis of gene expression and pre-messenger RNA (pre-mRNA) processing was probably employed to understand the underlying mechanisms.

Main Results:

  • Oncogenic MYC activation was found to be synthetically lethal with the inhibition of the core spliceosome.
  • MYC-driven tumor cells exhibit increased dependence on pre-mRNA processing for survival.
  • This dependence arises from MYC-induced cellular growth and heightened transcriptional activity.

Conclusions:

  • Targeting the spliceosome represents a viable synthetic lethal strategy to combat MYC-driven cancers.
  • This approach offers a promising avenue for therapeutic intervention where direct MYC targeting is difficult.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast07:31

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast

Published on: June 30, 2022

3.0K

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.6K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
7.3K